OLI Technologies
North Brunswick, US · Founded 2021 · Delaware corporation · 9 employees on LinkedIn · 2 known investors
OLI Technologies develops technology for decentralizing kidney care, working on chemistry, mechanical, and software engineering to support treatment outside centralized clinical settings. The company is developing a medical device, having completed its first animal study.
Founders & leadership
Board
CN
RL
Raymond LuoBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2025
▶$700KraisedFeb 2025 · 4 investors · Other Health CareRule 506(b)
▶$700KraisedFeb 2025 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Raymond LuoDirector
- Thomas WeindlExecutive Officer, Director
- Carl Nicholas NgDirector
- Offering amount
- $1M
- Amount sold
- $700K
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does OLI Technologies do?
- OLI Technologies develops technology for decentralizing kidney care, working on chemistry, mechanical, and software engineering to support treatment outside centralized clinical settings. The company is developing a medical device, having completed its first animal study.
- Who are OLI Technologies's investors?
- OLI Technologies's investors include Verge HealthTech Fund, BoxOne Ventures.
- How much funding has OLI Technologies raised?
- OLI Technologies has disclosed $700K raised across 1 round.
- Where is OLI Technologies headquartered?
- OLI Technologies is headquartered in North Brunswick, US.